Biomarker Project Awards
About this scheme
Applications will be accepted from scientists, clinicians or health care workers in UK universities, medical schools, hospitals and some research institutions.
Applications will be considered across biomarker discovery, assay development, qualification, or imaging discovery and evaluation.
Proposals can use invasive or imaging techniques and cover all types of biomarkers including predisposition, screening, diagnostic, prognostic, predictive, pharmacological and surrogate response.
We are particularly interested in applications that fall under the following areas:
- The qualification of predictive biomarkers for conventional cytotoxics (including radiation)
- Early detection biomarkers.
- Circulating biomarkers – cells and nucleic acids (proteomics excluded).
Applications will be judged based on how well the project proposal meets the following criteria:
- Science – Have you presented a clear scientific and clinical need for the biomarker? Do you have preliminary data to support your hypothesis?
- Samples – Do you have access to appropriate clinical samples? Is your assay robust?
- Scope – Do you have appropriate expertise in the proposed research team to undertake the project? Is there ‘line of sight’ to the clinic?
- Statistics – Is the study appropriately statistically powered to ensure significant results? Do you have a named biomarker statistician on your application?
For more specific details of research supported by Biomarker Project Awards and further information on review criteria, please refer to the scheme guidelines.
Funding support provided for:
- Salaries for researchers and technical staff
- Running expenses
Applications are assessed by the Experimental Medicine Expert Review Panel. Final funding recommendations are made by the Clinical Research Committee (CRC).
Our funding schemes award money raised through our charity fundraising, including, for translational research, by Stand Up To Cancer UK.
How to apply to this scheme
Applications for Biomarker Project Awards are considered twice a year. Applications will be assessed by international peer review from the biomarker field, before review by the Experimental Medicine Expert Review Panel. The final funding recommendation is made by the Clinical Research Committee.
Full application deadline
28 September 2015
1 December 2015
If you require more information or would like to discuss your application, please contact the office at least 2 months before the submission deadline.
All applications must be made through our electronic Grants Management System (eGMS).